TargetDual specificity protein kinase TTK [2-857](Homo sapiens (Human))
NERVIANO MEDICAL SCIENCES S.R.L.
US Patent
NERVIANO MEDICAL SCIENCES S.R.L.
US Patent
Affinity DataIC50: 200nMpH: 7.5Assay Description:The inhibitory activity of putative kinase inhibitors and the potency of selected compounds were determined using a trans-phosphorylation assay. Spec...More data for this Ligand-Target Pair
TargetDual specificity protein kinase TTK [2-857](Homo sapiens (Human))
NERVIANO MEDICAL SCIENCES S.R.L.
US Patent
NERVIANO MEDICAL SCIENCES S.R.L.
US Patent
Affinity DataIC50: 200nMpH: 7.5Assay Description:The inhibitory activity of putative kinase inhibitors and the potency of selected compounds were determined using a trans-phosphorylation assay. Spec...More data for this Ligand-Target Pair
TargetDual specificity protein kinase TTK [2-857](Homo sapiens (Human))
NERVIANO MEDICAL SCIENCES S.R.L.
US Patent
NERVIANO MEDICAL SCIENCES S.R.L.
US Patent
Affinity DataIC50: 200nMpH: 7.5Assay Description:The inhibitory activity of putative kinase inhibitors and the potency of selected compounds were determined using a trans-phosphorylation assay. Spec...More data for this Ligand-Target Pair
TargetDual specificity protein kinase TTK [2-857](Homo sapiens (Human))
NERVIANO MEDICAL SCIENCES S.R.L.
US Patent
NERVIANO MEDICAL SCIENCES S.R.L.
US Patent
Affinity DataIC50: 200nMpH: 7.5Assay Description:The inhibitory activity of putative kinase inhibitors and the potency of selected compounds were determined using a trans-phosphorylation assay. Spec...More data for this Ligand-Target Pair